Healthcare provider profile · identity verified

Leena Mehta, MD

Internal Medicine · SACRAMENTO, CA · NPI 1295001444

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	320	110
Levothyroxine Sodium	Levothyroxine Sodium	294	97
Hydrochlorothiazide	Hydrochlorothiazide	192	73
Amlodipine Besylate	Amlodipine Besylate	189	69
Lisinopril	Lisinopril	185	57
Losartan Potassium	Losartan Potassium	150	50
Meloxicam	Meloxicam	150	69
Albuterol Sulfate Hfa	Albuterol Sulfate	144	66
Famotidine	Famotidine	119	30
Metoprolol Tartrate	Metoprolol Tartrate	96	31
Gabapentin	Gabapentin	94	42
Alendronate Sodium	Alendronate Sodium	92	35
Pantoprazole Sodium	Pantoprazole Sodium	91	44
Trazodone Hcl	Trazodone Hcl	89	33
Fluticasone Propionate	Fluticasone Propionate	88	32
Metoprolol Succinate	Metoprolol Succinate	73	30
Ibuprofen	Ibuprofen	72	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	25
Simvastatin	Simvastatin	64	21
Atenolol	Atenolol	63	22
Sertraline Hcl	Sertraline Hcl	62	22
Rosuvastatin Calcium	Rosuvastatin Calcium	60	27
Alvesco	Ciclesonide	57	23
Hydroxyzine Hcl	Hydroxyzine Hcl	57	26
Fluoxetine Hcl	Fluoxetine Hcl	56	22
Acyclovir	Acyclovir	55	13
Tamsulosin Hcl	Tamsulosin Hcl	55	19
Duloxetine Hcl	Duloxetine Hcl	53	22
Bupropion Xl	Bupropion Hcl	49	12
Metformin Hcl Er	Metformin Hcl	46	19
Furosemide	Furosemide	45	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	40
Wixela Inhub	Fluticasone Propion/Salmeterol	43	12
Omeprazole	Omeprazole	39	18
Tizanidine Hcl	Tizanidine Hcl	37	15
Montelukast Sodium	Montelukast Sodium	35	14
Carvedilol	Carvedilol	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	26
Allopurinol	Allopurinol	33	12
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Prednisone	Prednisone	33	24
Metformin Hcl	Metformin Hcl	31	14
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	13
Breyna	Budesonide/Formoterol Fumarate	29	14
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	26	21
Lovastatin	Lovastatin	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Nabumetone	Nabumetone	22	18
Ondansetron Odt	Ondansetron	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	18
Estradiol	Estradiol	21	suppressed
Potassium Chloride	Potassium Chloride	21	11
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Baclofen	Baclofen	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	18
Humulin N	Insulin Nph Human Isophane	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	15
Propranolol Hcl	Propranolol Hcl	17	suppressed
Betamethasone Valerate	Betamethasone Valerate	16	11
Clonidine Hcl	Clonidine Hcl	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Ozempic	Semaglutide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Cephalexin	Cephalexin	15	14
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Colchicine	Colchicine	13	suppressed
Digoxin	Digoxin	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Retin-A	Tretinoin	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Eliquis	Apixaban	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error